{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:03:49Z","timestamp":1768777429549,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81400912"],"award-info":[{"award-number":["81400912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Program of Xiamen","award":["3502Z20154014"],"award-info":[{"award-number":["3502Z20154014"]}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.ijantimicag.2017.01.014","type":"journal-article","created":{"date-parts":[[2017,3,30]],"date-time":"2017-03-30T20:50:39Z","timestamp":1490907039000},"page":"603-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients"],"prefix":"10.1016","volume":"49","author":[{"given":"Jun","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengquan","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congxia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0010","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(12)61186-6","article-title":"Advances in treatment of bacterial meningitis","volume":"380","author":"van de Beek","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0015","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3109\/02688697.2015.1006168","article-title":"Methicillin-resistant Staphylococcus aureus central nervous system infections\u2014analysis and outcome","volume":"29","author":"Kumari","year":"2015","journal-title":"Br J Neurosurg"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2017.01.014_bib0020","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/491709","article-title":"Vancomycin: a history","volume":"42","author":"Levine","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0025","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3410\/M4-4","article-title":"Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates (\u2018the MIC creep\u2019): implications for therapy","volume":"4","author":"Dhand","year":"2012","journal-title":"F1000 Med Rep"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0030","doi-asserted-by":"publisher","first-page":"45","DOI":"10.7164\/antibiotics.57.45","article-title":"Ototoxicity of a new glycopeptide, norvancomycin with multiple intravenous administrations in guinea pigs","volume":"57","author":"Gao","year":"2004","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0035","first-page":"815","article-title":"The adverse reactions of parenteral norvancomycin in 1031 patients","volume":"43","author":"Liu","year":"2004","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0040","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1002\/elps.200400774","article-title":"Study on pharmacokinetics and tissue distribution of norvancomycin in rats by CE with electrochemical detection","volume":"27","author":"Zhou","year":"2006","journal-title":"Electrophoresis"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0045","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10096-016-2803-9","article-title":"Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy","volume":"36","author":"Wu","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0050","first-page":"7","article-title":"Creatinine clearance estimation from serum creatinine values: evaluation and comparison of five prediction formulae in Nigerian patients","volume":"29","author":"Sanusi","year":"2000","journal-title":"Afr J Med Med Sci"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0055","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1128\/AAC.44.5.1356-1358.2000","article-title":"Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit","volume":"44","author":"Albanese","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0060","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1086\/510390","article-title":"Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study","volume":"44","author":"Ricard","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0065","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jinf.2014.06.010","article-title":"Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study","volume":"69","author":"Shokouhi","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0070","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0075","first-page":"14","article-title":"Vancomycin for treating cerebrospinal fluid shunt infections in pediatric patients","volume":"10","author":"Thompson","year":"2005","journal-title":"J Pediatr Pharmacol Ther"},{"key":"10.1016\/j.ijantimicag.2017.01.014_bib0080","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1128\/AAC.35.12.2467","article-title":"Evaluation of vancomycin for therapy of adult pneumococcal meningitis","volume":"35","author":"Viladrich","year":"1991","journal-title":"Antimicrob Agents Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857917301012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T03:59:28Z","timestamp":1535947168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857917301012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0924857917301012"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.014","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and cerebrospinal fluid penetration of norvancomycin in Chinese adult patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}